| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/11/2013 | CN101815713B Polycyclic compound |
| 09/11/2013 | CN101679951B Telencephalic glial-restricted cell populations and related compositions and methods |
| 09/11/2013 | CN101611028B Substituted oxindole derivatives and their use as vasopressin receptor ligands |
| 09/11/2013 | CN101489591B Peptide compounds for the treatment of hyperexcitability disorders and diseases associated with ion channel dysfunction |
| 09/11/2013 | CN101175768B 促红细胞生成素变体 Erythropoietin variants |
| 09/10/2013 | US8530648 Diaza-spiro[5.5]undecanes |
| 09/10/2013 | US8530505 Substituted oxazolidinones and their use in the field of blood coagulation |
| 09/10/2013 | US8530504 Pyrazolothiazole compound |
| 09/10/2013 | US8530481 Stable pharmaceutical composition of freeze-dried tetrodotoxin powder |
| 09/10/2013 | US8530448 Compounds and methods for inhibiting selectin-mediated function |
| 09/10/2013 | US8530438 Vivo production of small interfering RNAs that mediate gene silencing |
| 09/10/2013 | US8530425 Targeted delivery of botulinum toxin to the sphenopalatine ganglion |
| 09/10/2013 | US8530407 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 09/10/2013 | US8529884 Using vector transformation to express herpes simple-1 viral gene sequences in cells; inducing immune response to pathogen attack |
| 09/10/2013 | CA2758894C Novel thyroid hormone .beta. receptor agonist |
| 09/10/2013 | CA2721670C 3-phenylpyrazolo[5,1-b]thiazole compound |
| 09/10/2013 | CA2691474C Cyanoisoquinoline |
| 09/10/2013 | CA2627837C Pharmaceutical compositions for alleviating discomfort |
| 09/10/2013 | CA2611430C Pharmaceutical compositions of a neuroactive steroid and uses thereof |
| 09/10/2013 | CA2611376C Therapeutic agents |
| 09/10/2013 | CA2566362C Treating seizures using ice inhibitors |
| 09/10/2013 | CA2559038C Processes for preparing substituted n-aryl-n'-[3-(1h-pyrazol-5-yl) phenyl] ureas and intermediates thereof |
| 09/10/2013 | CA2557758C Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder |
| 09/10/2013 | CA2505335C Method of treating movement disorders using barbituric acid derivatives |
| 09/10/2013 | CA2492498C Flea and tick octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 09/10/2013 | CA2451566C Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury |
| 09/10/2013 | CA2376693C Immunological control of .beta.-amyloid levels in vivo |
| 09/06/2013 | WO2013130890A1 Heterobicyclic compounds and their use as phosphodiesterase inhibitors |
| 09/06/2013 | WO2013130577A2 Compositions and methods for the treatment of migraine |
| 09/06/2013 | WO2013130422A1 Compositions and methods for treating mitochondrial diseases |
| 09/06/2013 | WO2013130402A1 N- (5s, 6s, 9r) - 5 -amino- 6 - (2, 3 - difluorophenyl) -6, 7, 8, 9 - tetrahydro - 5h - cyclohepta [b] pyridin-9 -yl- 4 - (2 - oxo-2, 3 - dihydro - 1h- imidazo [4, 5 -b] pyridin - 1 - yl) piperidine - 1 - carboxylate, hemisulfate salt |
| 09/06/2013 | WO2013130150A2 Metalloporphyrin neurological treatments |
| 09/06/2013 | WO2013129931A1 Method for improving functional synaptic connectivity |
| 09/06/2013 | WO2013128239A1 Use of engrailed for increasing dopamine synthesis by dopaminergic neurons |
| 09/06/2013 | WO2013127918A1 New therapeutic approaches for treating parkinson's disease |
| 09/06/2013 | WO2013127917A1 New compositions for treating amyotrophic lateral sclerosis |
| 09/06/2013 | WO2013127913A1 4,4-difluoro-piperidine-compounds |
| 09/06/2013 | WO2013127817A1 Imidazole derivatives as pde10a enzyme inhibitors |
| 09/06/2013 | WO2013127728A1 Hormone containing emulsion |
| 09/06/2013 | WO2013127727A1 Hormone containing emulsion comprising krill phospholipids |
| 09/06/2013 | WO2013126963A1 Pain treatment |
| 09/06/2013 | CA2856552A1 Metalloporphyrin neurological treatments |
| 09/06/2013 | CA2852042A1 Tamper resistant immediate release formulations |
| 09/05/2013 | US20130231367 Beta2-adrenoreceptor agonists |
| 09/05/2013 | US20130230600 Therapeutic agent |
| 09/05/2013 | US20130230500 Botulinum Toxin for Smoking Cessation |
| 09/04/2013 | EP2634188A1 Fused aminodihydropyrimidine derivative |
| 09/04/2013 | EP2634186A1 Naphthyridine derivative |
| 09/04/2013 | EP2634177A1 Tau imaging probe |
| 09/04/2013 | EP2633854A1 miRNA-9 or miRNA-9* for use in treating MND |
| 09/04/2013 | EP2633853A1 Long-term delivery formulations and methods of use thereof |
| 09/04/2013 | EP2632938A1 Peptide compound useful for inhibiting amyloid plaque formation |
| 09/04/2013 | EP2632924A1 Diaza-spiro[5.5]undecanes useful as orexin receptor antagonists |
| 09/04/2013 | EP2632918A1 Alpha-7 nicotinic receptor modulators for the treatment of pain, a psychotic disorder, cognitive impairment or alzheimer's disease |
| 09/04/2013 | EP2632488A1 Immunogenic compositions and methods for treating neurologic disorders |
| 09/04/2013 | EP2632468A1 Therapeutic compositions for diabetic symmetrical polyneuropathy |
| 09/04/2013 | EP2632466A2 Quinazoline derivatives, compositions, and uses related thereto |
| 09/04/2013 | EP2632461A1 Isoindolinone pde10 inhibitors |
| 09/04/2013 | EP2632444A1 TREATMENT OF MeCP2-ASSOCIATED DISORDERS |
| 09/04/2013 | EP2632254A2 Deuterium enriched rasagiline |
| 09/04/2013 | CN1622995B Receptor nucleic acids and polypeptides |
| 09/04/2013 | CN103282379A Nd2 peptides and methods of treating neurological disease |
| 09/04/2013 | CN103282374A Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory |
| 09/04/2013 | CN103282357A Pyrrolidine derivatives as NK3 antagonists |
| 09/04/2013 | CN103282353A Novel morphinans useful as analgesics |
| 09/04/2013 | CN103282349A Indole derivatives and process for their preparation |
| 09/04/2013 | CN103282043A Lissencephaly therapeutic agent |
| 09/04/2013 | CN103282026A Dosage form |
| 09/04/2013 | CN103275984A MCP-1 binding nucleic acids |
| 09/04/2013 | CN103275221A Human antibodies that bind human tnf alpha |
| 09/04/2013 | CN103275148A Preparation method of icariin |
| 09/04/2013 | CN103275075A 佐米曲普坦及其制备方法 Zolmitriptan and its preparation method |
| 09/04/2013 | CN103275070A Tetracyclic compound for adjusting proliferation of mononuclear cells and application of tetracyclic compound |
| 09/04/2013 | CN103275067A Inhibitors of histone deacetylase |
| 09/04/2013 | CN103272207A Traditional Chinese medicine for treating nerve headaches and preparation method of traditional Chinese medicine |
| 09/04/2013 | CN103272203A Foot bathing powder for dispelling cold and tranquillizing mind |
| 09/04/2013 | CN103272190A Chinese herbal compound for curing invasion of pericardium by evil, sleep talking and delirious speech |
| 09/04/2013 | CN103272129A Traditional Chinese medicine composition for treating neurodermatitis |
| 09/04/2013 | CN103272127A Preparation for treating epilepsy |
| 09/04/2013 | CN103272126A Traditional Chinese medicine for treating migraine |
| 09/04/2013 | CN103272124A Musk moxa stick for treating prosopoplegia |
| 09/04/2013 | CN103272109A Agent for curing brain cancer |
| 09/04/2013 | CN103272094A Traditional Chinese medicine composition for curing postherpetic neuralgia |
| 09/04/2013 | CN103272067A Quick-healing ointment for setting broken bones and connecting nerves |
| 09/04/2013 | CN103272063A Traditional Chinese medicine composition for treating women suffering from qi-stagnation |
| 09/04/2013 | CN103272018A Sedative and hypnotic active saponin components of spina date seed, as well as separation and purification method and application of sedative and hypnotic active saponin components |
| 09/04/2013 | CN103271997A Thermomagnetic treating plaster with functions of warming, activating meridian, promoting blood circulation and stopping pain |
| 09/04/2013 | CN103271981A Yufengningxin (medicine name) soft capsule and preparation method thereof |
| 09/04/2013 | CN103271944A Full-powder type capsule preparation |
| 09/04/2013 | CN103271943A Application of stem cell in preparation of preparation used for treating parkinson disease |
| 09/04/2013 | CN103271941A Novel application of zinc chloride serving as medicine for curing human brain glioma |
| 09/04/2013 | CN103271930A Pharmaceutical composition for treating diabetic feet caused by diabetes and acro-skin lesion and preparation method of pharmaceutical composition |
| 09/04/2013 | CN103271920A Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy |
| 09/04/2013 | CN103271905A Compounds for the treatment of peripheral neuropathies |
| 09/04/2013 | CN103271899A Application of Retigabine dihydrochloride crushing granularity in preparation |
| 09/04/2013 | CN103271890A 盐酸普拉克索胶囊及其制备方法 Pramipexole hydrochloride capsule and its preparation method |
| 09/04/2013 | CN103271889A Novel paliperidone progressively-increased release osmotic pump preparation and preparation method thereof |
| 09/04/2013 | CN103271888A 普瑞巴林口崩片和分散片及其制备方法 Pu Ruiba Linkou disintegrating tablets and tablet and its preparation method |
| 09/04/2013 | CN103271872A Industrial production method of penehyclidine hydrochloride injection |
| 09/04/2013 | CN103271854A Essential oil massage agent for promoting sleep and preparation method thereof |